Growth Factors of Ophthalmic Surgical Devices Market
The Ophthalmic Surgical Devices market size was valued at USD 8.79 billion in 2018, and the market is now projected tgrow from USD 8.79 billion in 2018 tUSD 17.70 billion by 2032, exhibiting a CAGR of 5.2% during the forecast period of 2019-2032.
The COVID-19 pandemic significantly impacted the Ophthalmic Surgical Devices market growth, with disruptions in manufacturing, supply chains, and elective surgical procedures due tlockdowns and healthcare resource reallocation. Many ophthalmic surgeries, such as cataract and refractive procedures, were deferred, leading treduced demand for surgical devices during the peak of the pandemic. Additionally, restrictions on hospital visits and concerns over virus transmission further delayed non-urgent eye care. However, as restrictions eased and healthcare systems adapted tsafety protocols, the market began recovering, driven by the resumption of postponed surgeries and increased focus on advanced ophthalmic solutions taddress growing patient backlogs.
The rising incidence of cataracts and glaucoma globally is drastically projected tforce the Ophthalmic Surgical Devices market share tincrease throughout the forecast length. For example, in keeping with current estimates, with the aid of the World Health Organization (WHO), around 20 million human beings throughout the globe are afflicted by cataracts. Additionally, a file posted using the National Ophthalmology Database (UK) in 2017 estimates that there are presently half one million humans stricken by glaucoma. The high occurrence of those ocular disorders is producing large opportunities within the field of ophthalmic surgeries, a good way tsubsequently bolster the boom of this marketplace over the forecast years.
Additionally, Growing awareness and accessibility tophthalmic devices and ophthalmic surgical instruments mixed with growing healthcare infrastructure in emerging countries are projected tpower the ophthalmic surgical devices market developments. Awareness concerning advanced ophthalmic diagnostic gadgets and surgical equipment is likewise increasing, leading ta better awareness and incidence fee of ocular diseases.
Comprehensive Analysis of Ophthalmic Surgical Devices Market
The ophthalmic surgical devices marketplace is segmented by way of surgical treatment type and quit-user. By surgical treatment type, it consists of cataract surgery gadgets (subdivided intphacoemulsification systems, femtosecond lasers, intraocular lenses, and ophthalmic viscoelastic gadgets and consumables), vitreoretinal surgical operation devices (bifurcated intgadget and consumables), and refractive blunders surgical procedure gadgets (segregated intdevice and consumables). By end-user, the marketplace is categorised inthospitals, ophthalmic clinics, and others, with hospitals accounting for the most important percentage in 2018 due tthe better volume of surgeries carried out. The increase in the hospital section is pushed through the increasing quantity of cataract and glaucoma surgeries, alongside improvements in healthcare infrastructure and facilities, particularly in growing countries.
North America generated a revenue of USD 2.82 billion in 2018 and is predicted thold a dominating function in the ophthalmic surgical devices market. High occurrence of glaucoma, cataract problems, and refractive errors, which require surgical intervention, are some of the main elements aiding the region tcapture a high market share.
Key players in the ophthalmic surgical devices market include Alcon (Switzerland), Johnson & Johnson Services, Inc. (USA), ZEISS International (Germany), Bausch & Lomb Incorporated (USA), STAAR Surgical (USA), Hoya Corporation (Japan), Glaukos (USA), Allergan (Ireland), and New World Medical, Inc. (USA). These companies are at the forefront of innovation and development in ophthalmic surgical solutions worldwide.
In April 2021- Bausch Lomb, a subsidiary of Bausch Health Companies Inc. Introduced that they had acquired U.S. FDA approval for their product ClearVisc dispersive ophthalmic viscosurgical device for patients having an ophthalmic surgical operation.
Segmentation Table
Global Ophthalmic Surgical Devices Market Scope
Study Period 2015-2026
Base Year 2018
Forecast Period 2019-2026
Growth Rate CAGR of 5.2% from 2024-2032
Historical Period 2015-2017
Unit Value (USD Billion)
Segmentation By surgery Type, End-User, and Region
By surgery Type
Cataract Surgery Devices
- Phacoemulsification Systems
- Femtosecond Laser
- Intraocular Lenses
- Ophthalmic Viscoelastic Devices & Other Consumables
Vitreoretinal Surgery Devices
- Equipment
- Consumables
Refractive Error Surgery
- Equipment
- Consumables
Glaucoma Surgery
By End-User
Hospitals
Ophthalmic Clinics
Others
By Region
North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Number of Cataract Surgeries - For Key Country/Region
- 4.2. Pipeline Analysis
- 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
- 4.4. Technological Advancements in Ophthalmic Surgery
- 4.5. Introduction of New Products / Approvals (by Major Players)
- 5. Global Ophthalmic Surgical Devices Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Surgery Type
- 5.2.1. Cataract Surgery Devices
- 5.2.1.1. Phacoemulsification Systems
- 5.2.1.2. Femtosecond Laser
- 5.2.1.3. Intraocular Lenses
- 5.2.1.4. Ophthalmic Viscoelastic Devices & Other Consumables
- 5.2.2. Vitreoretinal Surgery Devices
- 5.2.2.1. Equipment
- 5.2.2.2. Consumables
- 5.2.3. Refractive Error Surgery
- 5.2.3.1. Equipment
- 5.2.3.2. Consumables
- 5.2.4. Glaucoma Surgery
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Hospitals
- 5.3.2. Ophthalmic Clinics
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Ophthalmic Surgical Devices Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Surgery Type
- 6.2.1. Cataract Surgery Devices
- 6.2.1.1. Phacoemulsification Systems
- 6.2.1.2. Femtosecond Laser
- 6.2.1.3. Intraocular Lenses
- 6.2.1.4. Ophthalmic Viscoelastic Devices & Other Consumables
- 6.2.2. Vitreoretinal Surgery Devices
- 6.2.2.1. Equipment
- 6.2.2.2. Consumables
- 6.2.3. Refractive Error Surgery
- 6.2.3.1. Equipment
- 6.2.3.2. Consumables
- 6.2.4. Glaucoma Surgery
- 6.3. Market Analysis – By End-user
- 6.3.1. Hospitals
- 6.3.2. Ophthalmic Clinics
- 6.3.3. Others
- 6.4. Market Analysis – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Ophthalmic Surgical Devices Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Surgery Type
- 7.2.1. Cataract Surgery Devices
- 7.2.1.1. Phacoemulsification Systems
- 7.2.1.2. Femtosecond Laser
- 7.2.1.3. Intraocular Lenses
- 7.2.1.4. Ophthalmic Viscoelastic Devices & Other Consumables
- 7.2.2. Vitreoretinal Surgery Devices
- 7.2.2.1. Equipment
- 7.2.2.2. Consumables
- 7.2.3. Refractive Error Surgery
- 7.2.3.1. Equipment
- 7.2.3.2. Consumables
- 7.2.4. Glaucoma Surgery
- 7.3. Market Analysis – By End-user
- 7.3.1. Hospitals
- 7.3.2. Ophthalmic Clinics
- 7.3.3. Others
- 7.4. Market Analysis – By Country/Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia pacific Ophthalmic Surgical Devices Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Surgery Type
- 8.2.1. Cataract Surgery Devices
- 8.2.1.1. Phacoemulsification Systems
- 8.2.1.2. Femtosecond Laser
- 8.2.1.3. Intraocular Lenses
- 8.2.1.4. Ophthalmic Viscoelastic Devices & Other Consumables
- 8.2.2. Vitreoretinal Surgery Devices
- 8.2.2.1. Equipment
- 8.2.2.2. Consumables
- 8.2.3. Refractive Error Surgery
- 8.2.3.1. Equipment
- 8.2.3.2. Consumables
- 8.2.4. Glaucoma Surgery
- 8.3. Market Analysis – By End-user
- 8.3.1. Hospitals
- 8.3.2. Ophthalmic Clinics
- 8.3.3. Others
- 8.4. Market Analysis – By Country/Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Ophthalmic Surgical Devices Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Surgery Type
- 9.2.1. Cataract Surgery Devices
- 9.2.1.1. Phacoemulsification Systems
- 9.2.1.2. Femtosecond Laser
- 9.2.1.3. Intraocular Lenses
- 9.2.1.4. Ophthalmic Viscoelastic Devices & Other Consumables
- 9.2.2. Vitreoretinal Surgery Devices
- 9.2.2.1. Equipment
- 9.2.2.2. Consumables
- 9.2.3. Refractive Error Surgery
- 9.2.3.1. Equipment
- 9.2.3.2. Consumables
- 9.2.4. Glaucoma Surgery
- 9.3. Market Analysis – By End-user
- 9.3.1. Hospitals
- 9.3.2. Ophthalmic Clinics
- 9.3.3. Others
- 9.4. Market Analysis – By Country/Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Ophthalmic Surgical Devices Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Surgery Type
- 10.2.1. Cataract Surgery Devices
- 10.2.1.1. Phacoemulsification Systems
- 10.2.1.2. Femtosecond Laser
- 10.2.1.3. Intraocular Lenses
- 10.2.1.4. Ophthalmic Viscoelastic Devices & Other Consumables
- 10.2.2. Vitreoretinal Surgery Devices
- 10.2.2.1. Equipment
- 10.2.2.2. Consumables
- 10.2.3. Refractive Error Surgery
- 10.2.3.1. Equipment
- 10.2.3.2. Consumables
- 10.2.4. Glaucoma Surgery
- 10.3. Market Analysis – By End-user
- 10.3.1. Hospitals
- 10.3.2. Ophthalmic Clinics
- 10.3.3. Others
- 10.4. Market Analysis – By Country/Sub-region
- 10.4.1. GCC Countries
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles
- 11.5.1. Alcon (Part of Novartis AG)
- 11.5.1.1. Overview,
- 11.5.1.2. Products & services,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. strategies,
- 11.5.1.6. financials (based on availability)
- 11.5.2. Johnson and Johnson Services, Inc.
- 11.5.2.1. Overview,
- 11.5.2.2. Products & services,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. strategies,
- 11.5.2.6. financials (based on availability)
- 11.5.3. ZEISS International
- 11.5.3.1. Overview,
- 11.5.3.2. Products & services,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. strategies,
- 11.5.3.6. financials (based on availability)
- 11.5.4. Bausch & Lomb Incorporated
- 11.5.4.1. Overview,
- 11.5.4.2. Products & services,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. strategies,
- 11.5.4.6. financials (based on availability)
- 11.5.5. STAAR SURGICAL
- 11.5.5.1. Overview,
- 11.5.5.2. Products & services,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. strategies,
- 11.5.5.6. financials (based on availability)
- 11.5.6. Hoya Corporation
- 11.5.6.1. Overview,
- 11.5.6.2. Products & services,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. strategies,
- 11.5.6.6. financials (based on availability)
- 11.5.7. Glaukos
- 11.5.7.1. Overview,
- 11.5.7.2. Products & services,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. strategies,
- 11.5.7.6. financials (based on availability)
- 11.5.8. Allergan
- 11.5.8.1. Overview,
- 11.5.8.2. Products & services,
- 11.5.8.3. SWOT analysis,
- 11.5.8.4. Recent developments,
- 11.5.8.5. strategies,
- 11.5.8.6. financials (based on availability)
- 11.5.9. New World Medical, Inc
- 11.5.9.1. Overview,
- 11.5.9.2. Products & services,
- 11.5.9.3. SWOT analysis,
- 11.5.9.4. Recent developments,
- 11.5.9.5. strategies,
- 11.5.9.6. financials (based on availability)
- 11.5.10. Oertli Instrumente AG
- 11.5.10.1. Overview,
- 11.5.10.2. Products & services,
- 11.5.10.3. SWOT analysis,
- 11.5.10.4. Recent developments,
- 11.5.10.5. strategies,
- 11.5.10.6. financials (based on availability)
- 11.5.11. Other Prominent Players
- 11.5.11.1. Overview,
- 11.5.11.2. Products & services,
- 11.5.11.3. SWOT analysis,
- 11.5.11.4. Recent developments,
- 11.5.11.5. strategies,
- 11.5.11.6. financials (based on availability)
- 12. Strategic Recommendation "
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook